Диссертация (1146664), страница 24
Текст из файла (страница 24)
– 2008. – Vol. 582. – P. 573–578.277. Tan B. K., Adya R., Farhatullah S., et al. Metformin treatment may increaseomentin-1 levels in women with polycystic ovary syndrome // Diabetes. –2010. – Vol. 59. – P. 3023–3031.278. Tanabe K., Okuya S., Tanizawa Y. et al. Leptin induces proliferation ofpancreatic b cell line MIN6 through activation of mitogen-activated proteinkinase // Biochem. and Biophys.
Res. Commun. – 1997. – Vol. 241. – P. 765–768.279. Tchernof A., Toth. M. J., Poehlman E. T. Sex hormone-binding globulinlevels in middle-aged premenopausal women: Association with visceral obesityand metabolic profile // Diabrtes Care. – 1999. – Vol. 22. – P. 1875–1881.280. Temelkova-Kurktschiev T., Koehler C., Henkel E. Glycemic spikes are morestrongly associated with atherosclerosis than fasting glucose or HbAlc level //Diabetes Care. – 2000. – Vol.
23. – P. 1830–1834.281. Terrell A. M., Crisostomo P. R., Wairiuko G. M. et al. Jak/STAT/SOCSsignaling circuits and associated cytokine-mediated inflammation andhypertrophy in the heart // Shock. – 2006. – Vol. 26 (3). – P. 226–234.145282. Torng P. L., Su T. C., Sung F. C. et al. Effects of menopause onintraindividual changes in serum lipids, blood pressure, and body weight-theChin-Shan Community Cardiovascular Cohort study. // Atherosclerosis. 2002. - Vol. 161 (2). - P.
409-415.283. Tornwall J., Carey A. B., Fox R. I., Fox H. S. Estrogen in autoimmunity:expression of estrogen receptors in thymic and autoimmune T cells // J. Gend.Specif. Med. – 1999. – Vol. 2. – P. 33–40.284. Valensi P., Busy M., Combes M. E., Atali J. R. Microalbuminuria andhypertension in obese patients // Arch. Mal. Coeur. Vaiss. – 1992. – Vol. 85. –P. 1193–1195.285. Van der Veer E., Nong Z., O’Neil C., et al. Pre-B-cell colony-enhancingfactor regulates NADC-dependent protein deacetylase activity and promotesvascular smooth muscle cell maturation // Circulation Research.
– 2005. –Vol. 97. – P. 25–34.286. Vasan R. S. Cardiac function and obesity // Heart. – 2003. – Vol. 89. –P. 1127–1129.287. Vecchione C., Maffei A., Colella S., et al. Leptin effect on endothelial nitricoxideismediatedthroughAkt-endothelialnitricoxidesynthasephosphorylation pathway // Diabetes. – 2002. – Vol. 51. – P. 168–173.288.
Wallace A. M., McMahon A. D., Packard C. J., et al. Plasma leptin and therisk of cardiovascular disease in the west of Scotland coronary preventionstudy (WOSCOPS) // Circulation. – 2001. – Vol. 104. – P. 3052–3056.289. Wang J., Obici S., Morgan K., et al. Overfeeding rapidly induces leptin andinsulin resistance // Diabetes. – 2001. – Vol. 50. – P.
2786–2791.290. Wang J., Wang H., Luo W. et al. Leptin−Induced Endothelial Dysfunction IsMediated by Sympathetic Nervous System Activity // J. Am. Heart Assoc. –2013. – Vol. 2. – P. 299.291. Wang. Z., WangF. F., Zhu X. J. et al. Metabolic syndrome andmicroalbuminuria accompanied with hyperglycemia in community subjects //Zhonghua Yi Xue Za Zhi. – 2012. – Vol. 92 (36). – P. 2526–2529.146292.
Welborn T. A., Breckenridge A., Rubinstein A. H. et al. Serum insulin inessential hypertension and peripheral vascular disease // Lancet. – 1966. –Vol. 1. – P. 1336.293. Wiklund O., Hulthe J., Wlkstrand J. et al. Effect of controlled release /extended release metoprolol on carotid intima–media thickness in patients withhypercholesterolemia: a 3–year randomized study // Stroke. – 2002.
–Vol. 33. –P. 572–577.294. Wilson P. W., Kannell W. B. Silbershatz H., D'Agostino R.B. Clustering ofmetabolic factors and coronary heart disease // Arch. Intern. Med. 1999. –Vol. 159. – P. 1104–1109.295. Wittamer V., Franssen J. D., Vulcano M. et al. Specific recruitment ofantigen-presenting cells by chemerin, a novel processed ligand from humaninflammatory fluids // J. of Experimental Medicine. – 2003.
–Vol. 198. P. 977–985.296. Woo J., Cockram C. S., Swammathan R. et al. Microalbuminuria and othercardiovascular risk factors in nondiabetic subjects // Int. J. Cardiol. – 1992. –Vol. 37. – P. 345–350.297. Wu M., Han M., Li J. et al. 17beta-estradiol inhibits angiotensin II-inducedcardiac myofibroblast differentiation // Eur. J. Pharmacol. – 2009.
–Vol. 616 (1-3). – P. 155–159.298. Yamawaki H., Kuramoto J., Kameshima S. et al. Omentin, a noveladipocytokine inhibits TNF-induced vascular inflammation in humanendothelial cells // Biochem. and Biophys. Res. Commun. – 2011. – Vol. 408.– P. 339–343.299. Yamawaki H., Tsubaki N., Mukohda M. et al. Omentin, a novel adipokine,induces vasodilation in rat isolated blood vessels // Biochem. and Biophys.Res. Commun. – 2010. – Vol. 393. – P.
668–672.300. Yang T., Chu C. H., Hsu C. H. et al. Impact of metabolic syndrome on theincidence of chronic kidney disease: a Chinese cohort study // Nephrology(Carlton). – 2012. – Vol. 17 (6). – P. 532–538.147301. Zabel B. A., Zuniga L., Ohyama T. et al. Chemoattractants, extracellularproteases, and the integrated host defense response // ExperimentalHematology. – 2006. – Vol. 34. – P. 1021–1032.302. Zeidan A., Purdham D. M., Rajapurohitam V., et al. Leptin induces vascularsmooth muscle cell hypertrophy through angiotensin II – and endothelin-1dependent mechanisms and mediates stretch-induced hypertrophy // J.Pharmacol.
Exp. Ther. – 2005. – Vol. 315. – P. 1075–1084.303. Zelensky A. N., Gready J. E. The C-type lectin-like domain superfamily //FEBS J. – 2005. – Vol. 272. – P. 6179–6217.148.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
